Search

everythinglearnresearchcommunity

for

Search:↓

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Baricitinib is more effective than methotrexate for severe alopecia areata.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Topical flutamide works as well as hydroquinone for melasma but needs more safety checks.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Chinese women's hair gets thinner and grayer with age, and scalp conditions change, especially after 40.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Intradermal PRP significantly improved melasma in dark skin, with lasting results and no relapse after 3 months.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Umbilical cord masks can help reduce melasma in postpartum women.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

BM-PHA is as effective and safe as Restylane Perlane for improving nasolabial folds with minor side effects.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Hair loss causes social and psychological stress, leading people to spend more on treatment, regardless of how severe the hair loss is.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Guidelines help design better trials to compare alopecia areata treatments.

Chronic scarring alopecia is common in SLE patients and needs early detection and management.